Kinetic and HPV infection effects on cross-type neutralizing antibody and avidity responses induced by Cervarix(®)

BACKGROUND: We previously demonstrated that Cervarix(®) elicits antibody responses against vaccine-related types for which clinical efficacy was demonstrated (HPV-31 and -45). Here, we evaluated the kinetics of neutralization titers and avidity of Cervarix®-induced antibodies up to 36 months of foll...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kemp, Troy J., Safaeian, Mahboobeh, Hildesheim, Allan, Pan, Yuanji, Penrose, Kerri J., Porras, Carolina, Schiller, John T., Lowy, Douglas R., Herrero, Rolando, Pinto, Ligia A.
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3527627/
https://ncbi.nlm.nih.gov/pubmed/23123024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2012.10.067
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars